Inducible nitric oxide synthase and cyclooxgenase-2 mediate protection of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress in PC12 cells

Life Sciences

Volumn 79, Issue 9, 2006, Pages 870-876

  Tang, Xiao qing ^a,b   Yu, Hui min ^a   Zhi, Jun li ^a   Cui, Yu ^a   Tang, Er hu ^a   Feng, Jian qiang ^a   Chen, Pei xi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Nahua University   (China)

Author keywords

Apoptosis; Cyclooxygenase; Hydrogen superoxide; Inducible nitric oxide synthase; Preconditioning

Indexed keywords

AMINOGUANIDINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; HYDROGEN PEROXIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; INHIBITION KINETICS; NEUROPROTECTION; NEUROSECRETORY CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL NUCLEUS; CELL SURVIVAL; COLORING AGENTS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FLOW CYTOMETRY; HYDROGEN PEROXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITROBENZENES; OXIDATIVE STRESS; PC12 CELLS; RATS; SULFONAMIDES;

EID: 33745712190     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.03.010     Document Type: Article

References (28)

1. Adderley S.R., and Fitzgerald D.J. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. Journal of Biological Chemistry 274 (1999) 5038-5046
2. Arnaud C., Joyeux M., Garrel C., Godin-Ribuot D., Demenge P., and Ribuot C. Free-radical production triggered by hyperthermia contributes to heat stress-induced cardioprotection in isolated rat hearts. British Journal of Pharmacology 135 (2002) 1776-1782
3. Arnaud C., Joyeux-Faure M., Godin-Ribuot D., and Ribuot C. COX-2: an in vivo evidence of its participation in heat stress-induced myocardial preconditioning. Cardiovascular Research 58 (2003) 582-588
4. Bell R.M., Rees D.D., and Yellon D.M. The protection observed during delayed preconditioning of the heart appears independently of iNOS. Circulation 100 Suppl. I (1999) I-242 (Abstract)
5. Bolli R. The late phase of preconditioning. Circulation Research 87 (2000) 972-983
6. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: and overview of decade of research. Journal of Molecular and Cell Cardiology 33 (2001) 1897-1918
7. Dana A., Baxter G.F., and Yellon D.M. Delayed or second window preconditioning induced by adenosine A1 receptor activation is independent of early generation of nitric oxide or late induction of inducible nitric oxide synthase. Journal of Cardiovascular Pharmacology 38 (2001) 278-287
8. Guo Y., Jones W.K., Xuan Y.T., Tang X.L., Bao W., Wu W.J., Han H., Laubach V.E., Ping P., Yang Z., Qiu Y., and Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 11507-11512
9. Guo Y., Bao W., Tang X.L., Wu W.J., Takano H., and Bolli R. Pharmacological preconditioning (PC) with adenosine A and opioid δ1 receptor agonists is iNOS-dependent. Circulation 102 Suppl. II (2000) II-121
10. Guo Y., Bao W., Wu W.J., Shinmura K., Tang X.L., and Bolli R. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. Basic Research in Cardiology 95 (2000) 479-484
11. Iadecola C., Zhang F., and Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. American Journal of Physiology 268 (1995) R286-R292
12. Kodani E., Shinmura K., Xuan Y.T., Takano H., Auchampach J.A., Tang X.L., and Bolli R. Cyclooxygenase-2 does not mediate late preconditioδning induced by activation of adenosine A1 or A3 receptors. American Journal of Physiology. Heart and Circulatory Physiology 281 (2001) H959-H968
13. Kodani E., Xuan Y.T., Shinmura K., Takano H., Tang X.L., and Bolli R. Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. American Journal of Physiology. Heart and Circulatory Physiology 283 (2002) H1943-H1957
14. Konturek S.J., Brozozowski T., Pajdo R., Konturek P.C., Kwiecien S., Sliwowski Z., Pawlik M., Ptak A., Drozdowicz D., and Hahn E.G. Gastric preconditioning induced by short ischemia: the role of prostaglandins, nitric oxides and adenosine. Medical Science Monitor 7 (2001) 610-621
15. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
16. Nogawa S., Zhang F., Ross M.E., and Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. Journal of Neuroscience 17 (1997) 2746-2755
17. Patel H.H., Hsu A.K., and Gross G.J. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat. Life Sciences 75 (2004) 129-140
18. Sharma A., and Singh M. Protein kinase C activation and cardioprotective effect of preconditioning with oxidative stress in isolated rat heart. Molecular and Cellular Biochemistry 219 (2001) 1-6
19. Shinmura K., Tang X.L., Wang Y., Xuan Y.T., Liu S.O., Takano H., Bhatnagar A., and Bolli R. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proceedings of the National Academy of Sciences of United States of America 97 (2000) 10197-10202
20. Shinmura K., Nagai M., Tamaki K., Tani M., and Bolli R. COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts. American Journal of Physiology. Heart and Circulatory Physiology 283 (2002) H2534-H2543
21. Shinmura K., Xuan Y.T., Tang X.L., Kodani E., Han H., Zhu Y., and Bolli R. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circulation Research 90 (2002) 602-608
22. Smith W.L., Gavavito R.M., and Dewitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. Journal of Biological Chemistry 271 (1996) 33157-33160
23. Takano H., Manchikalapudi S., Tang X.L., Qiu Y., Rizvi A., Jadoon A.K., Zhang Q., and Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 98 (1998) 441-449
24. 2 in PC12 cells: mechanisms via MMP, ROS, and Bcl-2. Brain Research 1057 (2005) 57-64
25. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annual Review of Pharmacology and Toxicology 38 (1998) 97-120
26. Wang D., Yang X.P., Liu Y.H., Carretero O.A., and LaPointe M.C. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase. American Journal of Hypertension 12 (1999) 174-182
27. Zhao T., Xi L., Chelliah J., Levasseur J.E., and Kukreja R.C. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A1 receptors evidence from gene-knockout mice. Circulation 102 (2000) 902-907
28. Zwaka R.M., Zhou W., Zhang Y., Darby C.J., Dudus L., Halldorson J., Oberley L., and Engelhardt J.F. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nature Medicine 4 (1998) 698-704